Comparison of pimecrolimus and microneedling effects in the treatment of vitiligo

Comparing the treatment effects of microneedling, pimecrolimus and microneedling with pimecrolimus methods on the improvement of vitiligo patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190521043664N1

Enrollment

Registered

2020-03-15

Start date

2019-11-13

Completion date

Unknown

Last updated

2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo. Vitiligo

Interventions

Intervention 1: Intervention group2: application of pimecrolimus ointment on vitiligo lesion on two times a day for three months. Intervention 2: Intervention group1: microneedling on patient's vitili

Eligibility

Sex/Gender

All

Age

11 Years to 60 Years

Inclusion criteria

Inclusion criteria: Written consent to participate in the study Stability of the disease within the last year if the disease has not progressed in the last year Existence of lesions on the trunk and limb Patients who did not respond appropriately to phototherapy, topical and systemic therapy.

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Active vitiligo lesion Sensitivity to pimecrolimus Administration of systemic and topical treatments for vitiligo one month before enrollment

Design outcomes

Primary

Measure	Time frame
Photographic Scoring for patients with vitiligo. Timepoint: Before and 9 months after the study. Method of measurement: Score to photography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactzahra talebzadeh

Esfahan University of Medical Sciences

zahratalebzadeh61@gmail.com+98 31 3668 5555

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026